anmelden
OMX Nordic 40
2.692,70
PKT
+28,36
PKT
+1,06
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 17.04.24 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 17.04.24 | Ericsson (Telefon L.M.Ericsson) (B) Sell | Goldman Sachs Group Inc. | |
| 17.04.24 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 17.04.24 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 16.04.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 16.04.24 | Ericsson (Telefon L.M.Ericsson) (B) Sell | UBS AG | |
| 16.04.24 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
| 16.04.24 | Ericsson (Telefon L.M.Ericsson) (B) Buy | Jefferies & Company Inc. | |
| 16.04.24 | Nokia Neutral | JP Morgan Chase & Co. | |
| 15.04.24 | Volvo (B) Sell | UBS AG | |
| 15.04.24 | AstraZeneca Overweight | Barclays Capital | |
| 15.04.24 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 15.04.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 15.04.24 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 11.04.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 11.04.24 | Nokia Neutral | UBS AG | |
| 08.04.24 | AstraZeneca Overweight | Barclays Capital | |
| 08.04.24 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 07.04.24 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 05.04.24 | AstraZeneca Sell | UBS AG | |
| 05.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.04.24 | Nokia Hold | Jefferies & Company Inc. | |
| 04.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.04.24 | A.P. Moeller - Maersk A-S (B) Buy | UBS AG | |
| 03.04.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 02.04.24 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 02.04.24 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 28.03.24 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
| 28.03.24 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 28.03.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 28.03.24 | Hennes Mauritz (H M, H&M) Sell | Deutsche Bank AG | |
| 28.03.24 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 27.03.24 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 27.03.24 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
| 27.03.24 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 27.03.24 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 27.03.24 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 27.03.24 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 27.03.24 | Hennes Mauritz (H M, H&M) Sell | Deutsche Bank AG | |
| 27.03.24 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. |